Immunoassay Market Report 2026

Immunoassay Market Overview

• Immunoassay market size has reached to $37.32 billion in 2025 • Expected to grow to $52.83 billion in 2030 at a compound annual growth rate (CAGR) of 7.2% • Growth Driver: Rising Infectious And Chronic Diseases Drive Immunoassay Market Growth • Market Trend: Immunoassay Analyzers Are Gaining Traction In The Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Immunoassay Market?

Immunoassay is a bioanalytical test that employs antibody attachment to antigens to detect and quantify specific chemicals. Diseases can be diagnosed using immunoassays. Furthermore, information from test findings concerning an illness may be used to establish a course of therapy. This technique relies primarily on a competitive binding response for a finite number of receptors on an extremely specific anti-analyte antibody between a set quantity of labeled versions of an analyte and a substantial portion of an unmarked sample analyte. The main immunoassay product types are reagents and kits, analyzers or instruments, and software and services. A reagent is a material or product that can accelerate a reaction and is utilized in the majority of commonly used tests. The various specimens are blood, saliva, urine, and others applied to therapeutic drug monitoring, oncology, cardiology, endocrinology, infectious disease testing, autoimmune diseases and others. The end users are research and academic laboratories, home care settings, pharmaceutical and biotechnology companies and CROs, blood banks, hospitals and clinics, and clinical laboratories.

What Is The Immunoassay Market Growth Forecast?

The immunoassay market size is expected to see strong growth in the next few years. It will grow to $52.83 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to increasing demand for rapid diagnostics, rising investments in personalized medicine, expansion of decentralized testing models, growing adoption of digital laboratory workflows, increasing focus on companion diagnostics. Major trends in the forecast period include increasing adoption of high-sensitivity immunoassay kits, rising use of automated immunoassay analyzers, growing demand for point-of-care immunoassay testing, expansion of multiplex immunoassay platforms, enhanced integration of data management software.

What Is The Driver Of The Immunoassay Market?

The increasing numbers of infectious and chronic illnesses is expected to propel the growth of the immunoassay market going forward. Infectious and chronic illnesses refer to diseases caused by pathogens or long-term medical conditions that require ongoing monitoring, diagnosis, and management. Infectious and chronic illnesses are rising due to greater exposure to environmental pollutants, which weaken immunity and increase susceptibility to disease. The immunoassay market is witnessing increased demand as the rapid expansion of infectious and chronic illnesses pushes companies to adopt advanced diagnostic tools that enable early detection, disease surveillance, and accurate clinical decision-making. For instance, in June 2025, according to the UK Health Security Agency (UKHSA), a United Kingdom–based government public health agency, the number of reported Campylobacter cases in England increased from 60,055 in 2023 to 70,352 cases in 2024, reflecting a rise of 10,297 cases (17.1%) and an increase in the reporting rate from 104.1 to 121.9 per 100,000 population. Therefore, the increasing numbers of infectious and chronic illnesses is driving the demand for the immunoassay industry.

Key Players In The Global Immunoassay Market

Major companies operating in the immunoassay market are Siemens Healthineers GmbH, bioMérieux, Abbott, Beckman Coulter Inc., Quidel Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc, WAK-Chemie Medical GmbH, J Mitra & Co Pvt Ltd, Kamiya Biomedical Company, Tosoh Corporation, Gyros Protein Technologies AB, BioCheck Inc., Bio-Techn, DiaSorin S.p.A, Meso Scale Diagnostics LLC, QIAGE, Randox Laboratories Ltd., Shenzhen Mindray Bio-Medical Electronics Co Ltd, Danaher Corporation, Hologic Inc., Tecan Trading AG, Eurofins Scientific, Abcam plc, Enzo Biochem Inc., Luminex Corporation, Quanterix Corporation, Roche Diagnostics, ZEUS Scientific Inc.

Global Immunoassay Market Trends and Insights

Major companies operating in the immunoassay market are introducing innovative immunoassay analyzers to gain a competitive edge in the market. Immunoassay analyzers are laboratory instruments designed to automate and facilitate the detection and quantification of biological molecules, such as proteins or hormones, by utilizing immunological reactions. For instance, in May 2023, Beckman Coulter Diagnostics, a US-based company that develops products that simplify, automate, and innovate upon complex biomedical testing, launched the DxI 9000 Access Immunoassay Analyzer. DxI 9000 Access Immunoassay Analyzer addresses the demands of clinical laboratories for speed, reliability, reproducibility, quality, and menu expansion. It has shown the capability to develop increasingly sensitive and clinically relevant assays, amplifying the impact of new pharmaceutical therapies and ultimately improving patient outcomes. It features innovations such as new analyte processing and detection technology, precision sensors, smart algorithms, and remote real-time system monitoring, and is the only immunoassay analyzer system with no daily maintenance.

What Are Latest Mergers And Acquisitions In The Immunoassay Market?

In January 2023, Heska Corporation a US-based biotechnology company acquired MBio Diagnostics, Inc. for an undisclosed amount. With this acquisition,Heska Corporation aims to enhance its research and development and manufacturing capabilities, mainly through integrating LightDeck's innovative point-of-care technology, which will support the launch of advanced diagnostic platforms, including a canine cancer screening product. MBio Diagnostics, Inc. is a US-based company thatoffers immunoassays.

What Defines the Immunoassay Market?

The immunoassay market includes revenues earned by entities by supplying immunoassay kits, analyzers, and reagents. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Immunoassay Market Report 2026?

The immunoassay market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the immunoassay industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.